BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 19444675)

  • 1. HAART receipt and viral suppression among HIV-infected patients with co-occurring mental illness and illicit drug use.
    Chander G; Himelhoch S; Fleishman JA; Hellinger J; Gaist P; Moore RD; Gebo KA
    AIDS Care; 2009 May; 21(5):655-63. PubMed ID: 19444675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Access to HAART and utilization of inpatient medical hospital services among HIV-infected patients with co-occurring serious mental illness and injection drug use.
    Himelhoch S; Chander G; Fleishman JA; Hellinger J; Gaist P; Gebo KA
    Gen Hosp Psychiatry; 2007; 29(6):518-25. PubMed ID: 18022045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychiatric illness and virologic response in patients initiating highly active antiretroviral therapy.
    Pence BW; Miller WC; Gaynes BN; Eron JJ
    J Acquir Immune Defic Syndr; 2007 Feb; 44(2):159-66. PubMed ID: 17146374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Racial and gender disparities in receipt of highly active antiretroviral therapy persist in a multistate sample of HIV patients in 2001.
    Gebo KA; Fleishman JA; Conviser R; Reilly ED; Korthuis PT; Moore RD; Hellinger J; Keiser P; Rubin HR; Crane L; Hellinger FJ; Mathews WC;
    J Acquir Immune Defic Syndr; 2005 Jan; 38(1):96-103. PubMed ID: 15608532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Initiating highly active antiretroviral therapy and continuity of HIV care: the impact of incarceration and prison release on adherence and HIV treatment outcomes.
    Palepu A; Tyndall MW; Chan K; Wood E; Montaner JS; Hogg RS
    Antivir Ther; 2004 Oct; 9(5):713-9. PubMed ID: 15535408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV-1 RNA, CD4 T-lymphocytes, and clinical response to highly active antiretroviral therapy.
    Sterling TR; Chaisson RE; Moore RD
    AIDS; 2001 Nov; 15(17):2251-7. PubMed ID: 11698698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ethnicity as predictor of immune reconstitution among Malaysian HIV-positive patients treated with highly active antiretroviral therapy.
    Mohamad Isa II; Abu Bakar S; Ab Rahman AK
    J Med Virol; 2020 Aug; 92(8):1173-1181. PubMed ID: 31957025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment interruption in 30 HIV-infected patients with successful viral suppression under highly active antiretroviral treatment].
    Pavie J; Porcher R; Fournier S; André F; Tournoux C; Palmer P; Rabian C; Jean-Michel M
    Presse Med; 2005 Jun; 34(10 Suppl):1S8-13. PubMed ID: 16025661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of mental illness, substance use, and treatment for depression on the initiation of highly active antiretroviral therapy among HIV-infected individuals.
    Tegger MK; Crane HM; Tapia KA; Uldall KK; Holte SE; Kitahata MM
    AIDS Patient Care STDS; 2008 Mar; 22(3):233-43. PubMed ID: 18290749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunologic function and virologic suppression among children with perinatally acquired HIV Infection on highly active antiretroviral therapy.
    Rutstein RM; Gebo KA; Flynn PM; Fleishman JA; Sharp VL; Siberry GK; Spector SA
    Med Care; 2005 Sep; 43(9 Suppl):III15-22. PubMed ID: 16116305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Highly active antiretroviral therapy (HAART) among HIV-infected drug users: a prospective cohort study of sexual risk and injecting behaviour.
    Smit C; Lindenburg K; Geskus RB; Brinkman K; Coutinho RA; Prins M
    Addiction; 2006 Mar; 101(3):433-40. PubMed ID: 16499516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunological status and virological suppression among HIV-infected adults on highly active antiretroviral therapy.
    Melku M; Abebe G; Teketel A; Asrie F; Yalew A; Biadgo B; Kassa E; Damtie D; Anlay DZ
    Environ Health Prev Med; 2020 Aug; 25(1):43. PubMed ID: 32838734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Highly active antiretroviral therapy (HAART) retreatment in patients on CD4-guided therapy achieved similar virologic suppression compared with patients on continuous HAART: the HIV Netherlands Australia Thailand Research Collaboration 001.4 study.
    Ananworanich J; Siangphoe U; Hill A; Cardiello P; Apateerapong W; Hirschel B; Mahanontharit A; Ubolyam S; Cooper D; Phanuphak P; Ruxrungtham K
    J Acquir Immune Defic Syndr; 2005 Aug; 39(5):523-9. PubMed ID: 16044002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Substance abuse and psychiatric disorders in HIV-positive patients: epidemiology and impact on antiretroviral therapy.
    Chander G; Himelhoch S; Moore RD
    Drugs; 2006; 66(6):769-89. PubMed ID: 16706551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uptake and adherence to highly active antiretroviral therapy among HIV-infected people with alcohol and other substance use problems: the impact of substance abuse treatment.
    Palepu A; Horton NJ; Tibbetts N; Meli S; Samet JH
    Addiction; 2004 Mar; 99(3):361-8. PubMed ID: 14982549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD4+ cell count, viral load, and highly active antiretroviral therapy use are independent predictors of body composition alterations in HIV-infected adults: a longitudinal study.
    McDermott AY; Terrin N; Wanke C; Skinner S; Tchetgen E; Shevitz AH
    Clin Infect Dis; 2005 Dec; 41(11):1662-70. PubMed ID: 16267741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV-related medical service use by rural/urban residents: a multistate perspective.
    Wilson LE; Korthuis T; Fleishman JA; Conviser R; Lawrence PB; Moore RD; Gebo KA
    AIDS Care; 2011 Aug; 23(8):971-9. PubMed ID: 21400307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adherence and plasma HIV RNA responses to highly active antiretroviral therapy among HIV-1 infected injection drug users.
    Wood E; Montaner JS; Yip B; Tyndall MW; Schechter MT; O'Shaughnessy MV; Hogg RS
    CMAJ; 2003 Sep; 169(7):656-61. PubMed ID: 14517122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Factors Related to CD4+ T-Cell Recovery and Viral Suppression in Patients Who Have Low CD4+ T Cell Counts at the Initiation of HAART: A Retrospective Study of the National HIV Treatment Sub-Database of Zhejiang Province, China, 2014.
    He L; Pan X; Dou Z; Huang P; Zhou X; Peng Z; Zheng J; Zhang J; Yang J; Xu Y; Jiang J; Chen L; Jiang J; Wang N
    PLoS One; 2016; 11(2):e0148915. PubMed ID: 26900702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychiatric correlates of HAART utilization and viral load among HIV-positive impoverished persons.
    Carrico AW; Bangsberg DR; Weiser SD; Chartier M; Dilworth SE; Riley ED
    AIDS; 2011 May; 25(8):1113-8. PubMed ID: 21399478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.